Pediatric Neurology
Volume 34, Issue 1 , Pages 55-59 , January 2006

Levetiracetam in a Neonate With Malignant Migrating Partial Seizures

  • Ghassan Hmaimess, MD

      Affiliations

    • Neurologie Pédiatrique, Cliniques Universitaires Saint Luc (UCL), Brussels, Belgium
    • ,
  • Hazim Kadhim, MD, PhD

      Affiliations

    • Neurologie Pédiatrique, Cliniques Universitaires Saint Luc (UCL), Brussels, Belgium
    • Neuropathologie (ANAPATH), CHU Brugmann-HUDERF (ULB), Brussels, Belgium
    • Corresponding Author InformationCommunications should be addressed to: Dr. Kadhim; Neuropathology (ANAPATH); CHU Brugmann; Place van Gehuchten 4; 1020 Brussels, Belgium
    • ,
  • Marie-Cécile Nassogne, MD, PhD

      Affiliations

    • Neurologie Pédiatrique, Cliniques Universitaires Saint Luc (UCL), Brussels, Belgium
    • ,
  • Christine Bonnier, MD

      Affiliations

    • Neurologie Pédiatrique, Cliniques Universitaires Saint Luc (UCL), Brussels, Belgium
    • Centre Neurologique William-Lennox, LLN-Ottignies, Belgium
    • ,
  • Kenou van Rijckevorsel, MD, PhD

      Affiliations

    • Reference Center for Refractory Epilepsy, Cliniques Universitaires Saint Luc (UCL), Brussels, Belgium

Received 11 January 2005 ,Accepted 20 June 2005.

References 

  1. Coppola G , Plouin P , Chiron C , Robain O , Dulac O . Migrating partial seizures in infancy (A malignant disorder with developmental arrest) . Epilepsia . 1995;36:1017–1024
  2. Veneselli E , Perrone MV , Di Rocco M , Gaggero R , Biancheri R . Malignant migrating partial seizures in infancy . Epilepsy Res . 2001;46:27–32
  3. Wilmshurst JM , Appleton DB , Grattan-Smith PJ . Migrating partial seizures in infancy (Two new cases) . J Child Neurol . 2000;15:717–722
  4. Gross-Tsur V , Ben-Zeev B , Shalev RS . Malignant migrating partial seizures in infancy . Pediatr Neurol . 2004;31:287–290
  5. Hmaimess G , Kadhim H , Nassogne M-C , Bonnier C , van Rijckevorsel K . Migrating partial seizures in infancy (First report on a positive response to levetiracetam in youngest patient) . Epilepsia . 2004;45(3):204
  6. Shorvon SD , van Rijckevorsel K . A new antiepileptic drug . J Neurol Neurosur Ps . 2002;72:426–429
  7. Okuda K , Yasuhara A , Kamei A , Araki A , Kitamura N , Kobayashi Y . Successful control with bromide of two patients with malignant migrating partial seizures in infancy . Brain Dev . 2000;22:56–59
  8. Arroyo S , Crawford P . Safety profile of levetiracetam . Epileptic Disord . 2003;5:557–563
  9. Abou-Khalil B , Lazenby B . Long-term experience with levetiracetam . Epileptic Disord . 2003;5:533–537
  10. Lynch BA , Lambeng N , Nocka K , et al.   The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam . Proc Natl Acad Sci USA . 2004;101:9861–9866

PII: S0887-8994(05)00345-0

doi: 10.1016/j.pediatrneurol.2005.06.011

Pediatric Neurology
Volume 34, Issue 1 , Pages 55-59 , January 2006

Article Tools

* Image Usage & Resolution